Breakthrough technologies across four different drug classes to revolutionize medicine

Explore our product candidates

Based on our modular multi-platform approach we harness breakthrough technologies across four drug classes spanning 10 different modalities to create tailored treatment approaches for oncology and infectious diseases ushering in a new era of immunotherapies.

Stay up to date

Sign up for our email alert for news on our growing pipeline